Advertisement
Property:

How first-time buyers can get on the property ladder in a cost of living crisis

There are still ways to buy your first home – it may just involve going about things a little differently

Global Research Antibodies Market to Reach $6.6 Billion by 2030

ReportLinker
·25-min read
ReportLinker
ReportLinker

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

New York, May 08, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Research Antibodies Industry" - https://www.reportlinker.com/p06032766/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Research Antibodies Market to Reach $6.6 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Research Antibodies estimated at US$4.7 Billion in the year 2022, is projected to reach a revised size of US$6.6 Billion by 2030, growing at aCAGR of 4.2% over the period 2022-2030. Reagent, one of the segments analyzed in the report, is projected to record 3.9% CAGR and reach US$5.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Antibodies segment is readjusted to a revised 6.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 3.8% CAGR

The Research Antibodies market in the U.S. is estimated at US$1.4 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 3.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4% and 2.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Select Competitors (Total 42 Featured)
- Abcam plc
- Active Motif, Inc.
- Affinity Biologicals, Inc.
- Agilent Technologies, Inc.
- BD
- Beckman Coulter, Inc.
- Bethyl Laboratories, Inc.
- Bio SB
- BioLegend, Inc.
- Bio-Rad Laboratories, Inc.
- Cell Signaling Technology, Inc.
- Enzo Life Sciences, Inc.
- F. Hoffmann-La Roche Ltd
- GenScript
- Jackson ImmunoResearch Inc.
- Lonza
- Merck KGaA
- Miltenyi Biotec
- OriGene Technologies, Inc.
- PerkinElmer Inc.
- QIAGEN
- Rockland Immunochemicals, Inc.
- Sysmex Corporation
- Thermo Fisher Scientific Inc.


Read the full report: https://www.reportlinker.com/p06032766/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Research Antibodies - Global Key Competitors Percentage Market
Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Research Antibodies by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 2: World 8-Year Perspective for Research Antibodies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2023 & 2030

Table 3: World Recent Past, Current & Future Analysis for
Reagent by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 4: World 8-Year Perspective for Reagent by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2023 & 2030

Table 5: World Recent Past, Current & Future Analysis for
Antibodies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 6: World 8-Year Perspective for Antibodies by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for
Pharma & Biotech Companies by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 8: World 8-Year Perspective for Pharma & Biotech
Companies by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2023 & 2030

Table 9: World Recent Past, Current & Future Analysis for
Academic & Research Institutions by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 10: World 8-Year Perspective for Academic & Research
Institutions by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2023 & 2030

Table 11: World Recent Past, Current & Future Analysis for
Contract Research Organizations by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 12: World 8-Year Perspective for Contract Research
Organizations by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Western Blotting by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 14: World 8-Year Perspective for Western Blotting by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030

Table 15: World Recent Past, Current & Future Analysis for Flow
Cytometry by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 16: World 8-Year Perspective for Flow Cytometry by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030

Table 17: World Recent Past, Current & Future Analysis for
Enzyme-Linked Immunosorbent Assay (ELISA) by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 18: World 8-Year Perspective for Enzyme-Linked
Immunosorbent Assay (ELISA) by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for
Immunohistochemistry by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 20: World 8-Year Perspective for Immunohistochemistry by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030

Table 21: World Recent Past, Current & Future Analysis for
Immunofluorescence by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 22: World 8-Year Perspective for Immunofluorescence by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030

Table 23: World Recent Past, Current & Future Analysis for
Immunoprecipitation by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 24: World 8-Year Perspective for Immunoprecipitation by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030

Table 25: World Recent Past, Current & Future Analysis for
Other Technologies by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 26: World 8-Year Perspective for Other Technologies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030

Table 27: World Research Antibodies Market Analysis of Annual
Sales in US$ Million for Years 2014 through 2030

Table 28: World Recent Past, Current & Future Analysis for
Oncology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 29: World 8-Year Perspective for Oncology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2023 & 2030

Table 30: World Recent Past, Current & Future Analysis for
Infectious Diseases by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 31: World 8-Year Perspective for Infectious Diseases by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030

Table 32: World Recent Past, Current & Future Analysis for
Immunology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 33: World 8-Year Perspective for Immunology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2023 & 2030

Table 34: World Recent Past, Current & Future Analysis for Stem
Cells by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2022 through 2030 and
% CAGR

Table 35: World 8-Year Perspective for Stem Cells by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2023 & 2030

Table 36: World Recent Past, Current & Future Analysis for
Neurobiology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 37: World 8-Year Perspective for Neurobiology by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030

Table 38: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 39: World 8-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030

III. MARKET ANALYSIS

UNITED STATES
Research Antibodies Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2023 (E)
Table 40: USA Recent Past, Current & Future Analysis for
Research Antibodies by Product - Reagent and Antibodies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 41: USA 8-Year Perspective for Research Antibodies by
Product - Percentage Breakdown of Value Sales for Reagent and
Antibodies for the Years 2023 & 2030

Table 42: USA Recent Past, Current & Future Analysis for
Research Antibodies by End-Use - Pharma & Biotech Companies,
Academic & Research Institutions and Contract Research
Organizations - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 43: USA 8-Year Perspective for Research Antibodies by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Academic & Research Institutions and
Contract Research Organizations for the Years 2023 & 2030

Table 44: USA Recent Past, Current & Future Analysis for
Research Antibodies by Technology - Western Blotting, Flow
Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA),
Immunohistochemistry, Immunofluorescence, Immunoprecipitation
and Other Technologies - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 45: USA 8-Year Perspective for Research Antibodies by
Technology - Percentage Breakdown of Value Sales for Western
Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay
(ELISA), Immunohistochemistry, Immunofluorescence,
Immunoprecipitation and Other Technologies for the Years 2023 &
2030

Table 46: USA Recent Past, Current & Future Analysis for
Research Antibodies by Application - Oncology, Infectious
Diseases, Immunology, Stem Cells, Neurobiology and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 47: USA 8-Year Perspective for Research Antibodies by
Application - Percentage Breakdown of Value Sales for Oncology,
Infectious Diseases, Immunology, Stem Cells, Neurobiology and
Other Applications for the Years 2023 & 2030

CANADA
Table 48: Canada Recent Past, Current & Future Analysis for
Research Antibodies by Product - Reagent and Antibodies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 49: Canada 8-Year Perspective for Research Antibodies by
Product - Percentage Breakdown of Value Sales for Reagent and
Antibodies for the Years 2023 & 2030

Table 50: Canada Recent Past, Current & Future Analysis for
Research Antibodies by End-Use - Pharma & Biotech Companies,
Academic & Research Institutions and Contract Research
Organizations - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 51: Canada 8-Year Perspective for Research Antibodies by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Academic & Research Institutions and
Contract Research Organizations for the Years 2023 & 2030

Table 52: Canada Recent Past, Current & Future Analysis for
Research Antibodies by Technology - Western Blotting, Flow
Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA),
Immunohistochemistry, Immunofluorescence, Immunoprecipitation
and Other Technologies - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 53: Canada 8-Year Perspective for Research Antibodies by
Technology - Percentage Breakdown of Value Sales for Western
Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay
(ELISA), Immunohistochemistry, Immunofluorescence,
Immunoprecipitation and Other Technologies for the Years 2023 &
2030

Table 54: Canada Recent Past, Current & Future Analysis for
Research Antibodies by Application - Oncology, Infectious
Diseases, Immunology, Stem Cells, Neurobiology and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 55: Canada 8-Year Perspective for Research Antibodies by
Application - Percentage Breakdown of Value Sales for Oncology,
Infectious Diseases, Immunology, Stem Cells, Neurobiology and
Other Applications for the Years 2023 & 2030

JAPAN
Research Antibodies Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2023 (E)
Table 56: Japan Recent Past, Current & Future Analysis for
Research Antibodies by Product - Reagent and Antibodies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 57: Japan 8-Year Perspective for Research Antibodies by
Product - Percentage Breakdown of Value Sales for Reagent and
Antibodies for the Years 2023 & 2030

Table 58: Japan Recent Past, Current & Future Analysis for
Research Antibodies by End-Use - Pharma & Biotech Companies,
Academic & Research Institutions and Contract Research
Organizations - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 59: Japan 8-Year Perspective for Research Antibodies by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Academic & Research Institutions and
Contract Research Organizations for the Years 2023 & 2030

Table 60: Japan Recent Past, Current & Future Analysis for
Research Antibodies by Technology - Western Blotting, Flow
Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA),
Immunohistochemistry, Immunofluorescence, Immunoprecipitation
and Other Technologies - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 61: Japan 8-Year Perspective for Research Antibodies by
Technology - Percentage Breakdown of Value Sales for Western
Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay
(ELISA), Immunohistochemistry, Immunofluorescence,
Immunoprecipitation and Other Technologies for the Years 2023 &
2030

Table 62: Japan Recent Past, Current & Future Analysis for
Research Antibodies by Application - Oncology, Infectious
Diseases, Immunology, Stem Cells, Neurobiology and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 63: Japan 8-Year Perspective for Research Antibodies by
Application - Percentage Breakdown of Value Sales for Oncology,
Infectious Diseases, Immunology, Stem Cells, Neurobiology and
Other Applications for the Years 2023 & 2030

CHINA
Research Antibodies Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2023 (E)
Table 64: China Recent Past, Current & Future Analysis for
Research Antibodies by Product - Reagent and Antibodies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 65: China 8-Year Perspective for Research Antibodies by
Product - Percentage Breakdown of Value Sales for Reagent and
Antibodies for the Years 2023 & 2030

Table 66: China Recent Past, Current & Future Analysis for
Research Antibodies by End-Use - Pharma & Biotech Companies,
Academic & Research Institutions and Contract Research
Organizations - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 67: China 8-Year Perspective for Research Antibodies by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Academic & Research Institutions and
Contract Research Organizations for the Years 2023 & 2030

Table 68: China Recent Past, Current & Future Analysis for
Research Antibodies by Technology - Western Blotting, Flow
Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA),
Immunohistochemistry, Immunofluorescence, Immunoprecipitation
and Other Technologies - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 69: China 8-Year Perspective for Research Antibodies by
Technology - Percentage Breakdown of Value Sales for Western
Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay
(ELISA), Immunohistochemistry, Immunofluorescence,
Immunoprecipitation and Other Technologies for the Years 2023 &
2030

Table 70: China Recent Past, Current & Future Analysis for
Research Antibodies by Application - Oncology, Infectious
Diseases, Immunology, Stem Cells, Neurobiology and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 71: China 8-Year Perspective for Research Antibodies by
Application - Percentage Breakdown of Value Sales for Oncology,
Infectious Diseases, Immunology, Stem Cells, Neurobiology and
Other Applications for the Years 2023 & 2030

EUROPE
Research Antibodies Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2023 (E)
Table 72: Europe Recent Past, Current & Future Analysis for
Research Antibodies by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2022 through 2030 and %
CAGR

Table 73: Europe 8-Year Perspective for Research Antibodies by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2023 & 2030

Table 74: Europe Recent Past, Current & Future Analysis for
Research Antibodies by Product - Reagent and Antibodies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 75: Europe 8-Year Perspective for Research Antibodies by
Product - Percentage Breakdown of Value Sales for Reagent and
Antibodies for the Years 2023 & 2030

Table 76: Europe Recent Past, Current & Future Analysis for
Research Antibodies by End-Use - Pharma & Biotech Companies,
Academic & Research Institutions and Contract Research
Organizations - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 77: Europe 8-Year Perspective for Research Antibodies by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Academic & Research Institutions and
Contract Research Organizations for the Years 2023 & 2030

Table 78: Europe Recent Past, Current & Future Analysis for
Research Antibodies by Technology - Western Blotting, Flow
Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA),
Immunohistochemistry, Immunofluorescence, Immunoprecipitation
and Other Technologies - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 79: Europe 8-Year Perspective for Research Antibodies by
Technology - Percentage Breakdown of Value Sales for Western
Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay
(ELISA), Immunohistochemistry, Immunofluorescence,
Immunoprecipitation and Other Technologies for the Years 2023 &
2030

Table 80: Europe Recent Past, Current & Future Analysis for
Research Antibodies by Application - Oncology, Infectious
Diseases, Immunology, Stem Cells, Neurobiology and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 81: Europe 8-Year Perspective for Research Antibodies by
Application - Percentage Breakdown of Value Sales for Oncology,
Infectious Diseases, Immunology, Stem Cells, Neurobiology and
Other Applications for the Years 2023 & 2030

FRANCE
Research Antibodies Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2023 (E)
Table 82: France Recent Past, Current & Future Analysis for
Research Antibodies by Product - Reagent and Antibodies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 83: France 8-Year Perspective for Research Antibodies by
Product - Percentage Breakdown of Value Sales for Reagent and
Antibodies for the Years 2023 & 2030

Table 84: France Recent Past, Current & Future Analysis for
Research Antibodies by End-Use - Pharma & Biotech Companies,
Academic & Research Institutions and Contract Research
Organizations - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 85: France 8-Year Perspective for Research Antibodies by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Academic & Research Institutions and
Contract Research Organizations for the Years 2023 & 2030

Table 86: France Recent Past, Current & Future Analysis for
Research Antibodies by Technology - Western Blotting, Flow
Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA),
Immunohistochemistry, Immunofluorescence, Immunoprecipitation
and Other Technologies - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 87: France 8-Year Perspective for Research Antibodies by
Technology - Percentage Breakdown of Value Sales for Western
Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay
(ELISA), Immunohistochemistry, Immunofluorescence,
Immunoprecipitation and Other Technologies for the Years 2023 &
2030

Table 88: France Recent Past, Current & Future Analysis for
Research Antibodies by Application - Oncology, Infectious
Diseases, Immunology, Stem Cells, Neurobiology and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 89: France 8-Year Perspective for Research Antibodies by
Application - Percentage Breakdown of Value Sales for Oncology,
Infectious Diseases, Immunology, Stem Cells, Neurobiology and
Other Applications for the Years 2023 & 2030

GERMANY
Research Antibodies Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2023 (E)
Table 90: Germany Recent Past, Current & Future Analysis for
Research Antibodies by Product - Reagent and Antibodies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 91: Germany 8-Year Perspective for Research Antibodies by
Product - Percentage Breakdown of Value Sales for Reagent and
Antibodies for the Years 2023 & 2030

Table 92: Germany Recent Past, Current & Future Analysis for
Research Antibodies by End-Use - Pharma & Biotech Companies,
Academic & Research Institutions and Contract Research
Organizations - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 93: Germany 8-Year Perspective for Research Antibodies by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Academic & Research Institutions and
Contract Research Organizations for the Years 2023 & 2030

Table 94: Germany Recent Past, Current & Future Analysis for
Research Antibodies by Technology - Western Blotting, Flow
Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA),
Immunohistochemistry, Immunofluorescence, Immunoprecipitation
and Other Technologies - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 95: Germany 8-Year Perspective for Research Antibodies by
Technology - Percentage Breakdown of Value Sales for Western
Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay
(ELISA), Immunohistochemistry, Immunofluorescence,
Immunoprecipitation and Other Technologies for the Years 2023 &
2030

Table 96: Germany Recent Past, Current & Future Analysis for
Research Antibodies by Application - Oncology, Infectious
Diseases, Immunology, Stem Cells, Neurobiology and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 97: Germany 8-Year Perspective for Research Antibodies by
Application - Percentage Breakdown of Value Sales for Oncology,
Infectious Diseases, Immunology, Stem Cells, Neurobiology and
Other Applications for the Years 2023 & 2030

ITALY
Table 98: Italy Recent Past, Current & Future Analysis for
Research Antibodies by Product - Reagent and Antibodies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 99: Italy 8-Year Perspective for Research Antibodies by
Product - Percentage Breakdown of Value Sales for Reagent and
Antibodies for the Years 2023 & 2030

Table 100: Italy Recent Past, Current & Future Analysis for
Research Antibodies by End-Use - Pharma & Biotech Companies,
Academic & Research Institutions and Contract Research
Organizations - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 101: Italy 8-Year Perspective for Research Antibodies by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Academic & Research Institutions and
Contract Research Organizations for the Years 2023 & 2030

Table 102: Italy Recent Past, Current & Future Analysis for
Research Antibodies by Technology - Western Blotting, Flow
Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA),
Immunohistochemistry, Immunofluorescence, Immunoprecipitation
and Other Technologies - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 103: Italy 8-Year Perspective for Research Antibodies by
Technology - Percentage Breakdown of Value Sales for Western
Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay
(ELISA), Immunohistochemistry, Immunofluorescence,
Immunoprecipitation and Other Technologies for the Years 2023 &
2030

Table 104: Italy Recent Past, Current & Future Analysis for
Research Antibodies by Application - Oncology, Infectious
Diseases, Immunology, Stem Cells, Neurobiology and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 105: Italy 8-Year Perspective for Research Antibodies by
Application - Percentage Breakdown of Value Sales for Oncology,
Infectious Diseases, Immunology, Stem Cells, Neurobiology and
Other Applications for the Years 2023 & 2030

UNITED KINGDOM
Research Antibodies Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United Kingdom for 2023 (E)
Table 106: UK Recent Past, Current & Future Analysis for
Research Antibodies by Product - Reagent and Antibodies -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

Table 107: UK 8-Year Perspective for Research Antibodies by
Product - Percentage Breakdown of Value Sales for Reagent and
Antibodies for the Years 2023 & 2030

Table 108: UK Recent Past, Current & Future Analysis for
Research Antibodies by End-Use - Pharma & Biotech Companies,
Academic & Research Institutions and Contract Research
Organizations - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 109: UK 8-Year Perspective for Research Antibodies by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Academic & Research Institutions and
Contract Research Organizations for the Years 2023 & 2030

Table 110: UK Recent Past, Current & Future Analysis for
Research Antibodies by Technology - Western Blotting, Flow
Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA),
Immunohistochemistry, Immunofluorescence, Immunoprecipitation
and Other Technologies - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 111: UK 8-Year Perspective for Research Antibodies by
Technology - Percentage Breakdown of Value Sales for Western
Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay
(ELISA), Immunohistochemistry, Immunofluorescence,
Immunoprecipitation and Other Technologies for the Years 2023 &
2030

Table 112: UK Recent Past, Current & Future Analysis for
Research Antibodies by Application - Oncology, Infectious
Diseases, Immunology, Stem Cells, Neurobiology and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 113: UK 8-Year Perspective for Research Antibodies by
Application - Percentage Breakdown of Value Sales for Oncology,
Infectious Diseases, Immunology, Stem Cells, Neurobiology and
Other Applications for the Years 2023 & 2030

REST OF EUROPE
Table 114: Rest of Europe Recent Past, Current & Future
Analysis for Research Antibodies by Product - Reagent and
Antibodies - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 115: Rest of Europe 8-Year Perspective for Research
Antibodies by Product - Percentage Breakdown of Value Sales for
Reagent and Antibodies for the Years 2023 & 2030

Table 116: Rest of Europe Recent Past, Current & Future
Analysis for Research Antibodies by End-Use - Pharma & Biotech
Companies, Academic & Research Institutions and Contract
Research Organizations - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 117: Rest of Europe 8-Year Perspective for Research
Antibodies by End-Use - Percentage Breakdown of Value Sales for
Pharma & Biotech Companies, Academic & Research Institutions
and Contract Research Organizations for the Years 2023 & 2030

Table 118: Rest of Europe Recent Past, Current & Future
Analysis for Research Antibodies by Technology - Western
Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay
(ELISA), Immunohistochemistry, Immunofluorescence,
Immunoprecipitation and Other Technologies - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 119: Rest of Europe 8-Year Perspective for Research
Antibodies by Technology - Percentage Breakdown of Value Sales
for Western Blotting, Flow Cytometry, Enzyme-Linked
Immunosorbent Assay (ELISA), Immunohistochemistry,
Immunofluorescence, Immunoprecipitation and Other Technologies
for the Years 2023 & 2030

Table 120: Rest of Europe Recent Past, Current & Future
Analysis for Research Antibodies by Application - Oncology,
Infectious Diseases, Immunology, Stem Cells, Neurobiology and
Other Applications - Independent Analysis of Annual Sales in
US$ Million for the Years 2022 through 2030 and % CAGR

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032766/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001